Comparing PET scan methods for cancer patients
Part of Cancer clinical trials.
This trial compares different ways to measure sugar uptake in PET/CT scans for cancer. It aims to see which method gives the most accurate results to help guide your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have a cancer diagnosis and are scheduled for an FDG-PET/CT scan.
- Your cancer is not so widespread that it has extensive metastases in many places.
- You do not have non-cancer conditions causing high sugar uptake, like active inflammation or widely active bone marrow.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain factors affect the way a radioactive tracer called FDG is taken up by normal organs and tumors. It may help improve the accuracy of PET scans for cancer patients.
This study checks whether a specific analysis method (called FUR) can better measure how much “sugar” from PET scans is used by tumors. It uses regular PET/CT scans you may already get as part of standard care, and compares how the measurements work.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This study compares two types of PET scans (FDG and FAPI) in people with suspected or newly diagnosed cancer. It aims to learn which scan gives better images of different cancers, potentially helping guide treatment decisions.
This study compares two types of PET/CT scans—one that uses FDG and one that uses FAPI—to help doctors see and evaluate cancer in different situations. It may help improve how well scans detect tumors and guide care, though it requires getting both scans scheduled.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
Hear when a new Cancer Patients Referred to do PET/CT Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.